APA-viite

Shi, B., Behrens, C., Vaghani, V., Riquelme, E. M., Rodriguez‐Canales, J., Kadara, H., . . . Simon, G. (2019). Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer. Cancer Med.

Chicago-tyylinen lähdeviittaus

Shi, Bin, et al. "Oncogenic Enhancer of Zeste Homolog 2 Is an Actionable Target in Patients With Non‐small Cell Lung Cancer." Cancer Med 2019.

MLA-viite

Shi, Bin, et al. "Oncogenic Enhancer of Zeste Homolog 2 Is an Actionable Target in Patients With Non‐small Cell Lung Cancer." Cancer Med 2019.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.